SlideShare a Scribd company logo
1 of 12
Leukemia
• Leukemia is a blood cancer caused by a rise in the number of
white blood cells in your body.
• Those white blood cells crowd out the red blood cells and
platelets that your body needs to be healthy. The extra white
blood cells don’t work right
Leukemia Symptoms
• Different types of leukemia can cause different problems. You might not notice any signs
in the early stages of some forms. When you do have symptoms, they may include:
• Weakness or fatigue
• Bruising or bleeding easily
• Fever or chills
• Infections that are severe or keep coming back
• Pain in your bones or joints
• Headaches
• Vomiting
• Seizures
• Weight loss
• Night sweats
• Shortness of breath
• Swollen lymph nodes or organs like your spleen
•
• Blood has three types of cells: white blood cells that fight infection,
red blood cells that carry oxygen, and platelets that help blood clot.
• Every day, your bone marrow makes billions of new blood cells, and
most of them are red cells. When you have leukemia, your body
makes more white cells than it needs.
• These leukemia cells can’t fight infection the way normal white blood
cells do. And because there are so many of them, they start to affect
the way your organs work. Over time, you may not have enough red
blood cells to supply oxygen, enough platelets to clot your blood, or
enough normal white blood cells to fight infection
Leukemia Classification
• Leukemia is grouped by how fast it develops and gets worse, and by
which type of blood cell is involved.
• The first group, how fast it develops, is divided
into acute and chronic leukemia.
• Acute leukemia happens when most of the abnormal blood cells
don’t mature and can’t carry out normal functions. It can get bad
very fast.
• Chronic leukemia happens when there are some immature cells, but
others are normal and can work the way they should. It gets bad
more slowly than acute forms do.
•
• The second group, what type of cell is involved, is divided
into lymphocytic and myelogenous leukemia.
• Lymphocytic (or lymphoblastic) leukemia involves bone marrow
cells that become lymphocytes, a kind of white blood cell.
• Myelogenous (or myeloid) leukemia involves the marrow cells
that create red blood cells, platelets, and other kinds of white
blood cells
Types of Leukemia
• The four main types of leukemia are:
• Acute lymphocytic leukemia (ALL). This is the most common form
of childhood leukemia. It can spread to your lymph nodes and central
nervous system.
• Acute myelogenous leukemia (AML). This is the second most common
form of childhood leukemia and one of the most common forms for
adults.
• Chronic lymphocytic leukemia (CLL). This is the other most common
form of adult leukemia. Some kinds of CLL will be stable for years and
won’t need treatment. But with others, your body isn’t able to create
normal blood cells, and you’ll need treatment.
• Chronic myelogenous leukemia (CML). With this form, you might not
have noticeable symptoms. You might not be diagnosed with it until you
have a routine blood test. People 65 and older have a higher risk of this
type.
How leukemia forms
• In general, leukemia is thought to occur when some blood cells
acquire changes (mutations) in their genetic material or DNA. A
cell's DNA contains the instructions that tell a cell what to do.
Normally, the DNA tells the cell to grow at a set rate and to die
at a set time. In leukemia, the mutations tell the blood cells to
continue growing and dividing.
• When this happens, blood cell production becomes out of
control. Over time, these abnormal cells can crowd out healthy
blood cells in the bone marrow, leading to fewer healthy white
blood cells, red blood cells and platelets, causing the signs and
symptoms of leukemia.
Risk factors
• Previous cancer treatment. People who've had certain types of
chemotherapy and radiation therapy for other cancers have an increased
risk of developing certain types of leukemia.
• Genetic disorders. Genetic abnormalities seem to play a role in the
development of leukemia. Certain genetic disorders, such as Down
syndrome, are associated with an increased risk of leukemia.
• Exposure to certain chemicals. Exposure to certain chemicals, such as
benzene — which is found in gasoline and is used by the chemical
industry — is linked to an increased risk of some kinds of leukemia.
• Smoking. Smoking cigarettes increases the risk of acute myelogenous
leukemia.
• Family history of leukemia. If members of your family have been
diagnosed with leukemia, your risk of the disease may be increased.
Cont…….
• With regard to the specific genetic and environmental factors that are thought to be linked to
leukemia, and what causes bone marrow cells to mutate, researchers are evaluating certain
combinations of:
• A genetic predisposition
• Down syndrome
• Human T-lymphotropic virus (HTLV)
• Human immunodeficiency virus (HIV)
• Exposure to petrochemicals, such as benzene
• Extensive exposure to artificial ionizing radiation
• Alkylating chemotherapy agents administered to treat other types of cancer
• Tobacco use
• Use of certain hair dyes
Can Leukemia be cured?
• While there is no cure for leukemia at this point in time, and the cancer can still
recur, patients can reach a state of remission (in which there are no longer any
signs or symptoms of cancer). These days, there are a range of advanced treatment
options available for leukemia patients to achieve remission without recurrence,
including:
• Chemotherapy
• Radiation therapy
• Bone marrow transplants
• Monoclonal antibody therapy
• Immunotherapy
• Clinical trials
Treatments
• Induction chemotherapy to bring about bone marrow remission. For adults, standard induction
plans include prednisone, vincristine, and an anthracycline drug; other drug plans may
include L-asparaginase or cyclophosphamide. For children with low-risk ALL, standard therapy
usually consists of three drugs (prednisone, L-asparaginase, and vincristine) for the first month
of treatment.
• Consolidation therapy or intensification therapy to eliminate any remaining leukemia cells.
There are many different approaches to consolidation, but it is typically a high-dose, multi-drug
treatment that is undertaken for a few months. People with low- to average-risk ALL receive
therapy with antimetabolite drugs such as methotrexate and 6-mercaptopurine (6-MP). People
who are high-risk receive higher drug doses of these drugs, plus additional drugs.
• CNS prophylaxis (preventive therapy) to stop cancer from spreading to the brain and nervous
system in high-risk people. Standard prophylaxis may include radiation of the head and/or
drugs delivered directly into the spine.
• Maintenance treatments with chemotherapeutic drugs to prevent disease recurrence once
remission has been achieved. Maintenance therapy usually involves lower drug doses and
may continue for up to three years.
• Alternatively, allogeneic bone marrow transplantation may be appropriate for high-risk or
relapsed people.

More Related Content

Similar to Leukemia.pptx (20)

Paediatric malignancies ppt
Paediatric malignancies pptPaediatric malignancies ppt
Paediatric malignancies ppt
 
Leukemia
Leukemia Leukemia
Leukemia
 
leukemia and lymphoma
leukemia and lymphoma leukemia and lymphoma
leukemia and lymphoma
 
Leukemia.pptx
Leukemia.pptxLeukemia.pptx
Leukemia.pptx
 
4 causes of leukemia
4 causes of leukemia 4 causes of leukemia
4 causes of leukemia
 
Leukemia
LeukemiaLeukemia
Leukemia
 
Leukemias
LeukemiasLeukemias
Leukemias
 
Best Blood Cancer Specialist Delhi NCR.pptx
Best Blood Cancer Specialist Delhi NCR.pptxBest Blood Cancer Specialist Delhi NCR.pptx
Best Blood Cancer Specialist Delhi NCR.pptx
 
Blood and its components Part 2
Blood and its components Part 2Blood and its components Part 2
Blood and its components Part 2
 
Study of leukemia
Study of leukemia Study of leukemia
Study of leukemia
 
Leukemia@pradhuman.ppts
Leukemia@pradhuman.pptsLeukemia@pradhuman.ppts
Leukemia@pradhuman.ppts
 
What is the difference between leukemia and blood cancer
What is the difference between leukemia and blood cancerWhat is the difference between leukemia and blood cancer
What is the difference between leukemia and blood cancer
 
Babitha's Notes on leukemia
Babitha's Notes on leukemiaBabitha's Notes on leukemia
Babitha's Notes on leukemia
 
LEUKEMIA
LEUKEMIALEUKEMIA
LEUKEMIA
 
Leukemia
LeukemiaLeukemia
Leukemia
 
Lukemia powerpoint
Lukemia powerpointLukemia powerpoint
Lukemia powerpoint
 
Blood Disorders Awareness
Blood Disorders AwarenessBlood Disorders Awareness
Blood Disorders Awareness
 
Leukemia
LeukemiaLeukemia
Leukemia
 
leukemia
leukemialeukemia
leukemia
 
Blood cancer
Blood cancerBlood cancer
Blood cancer
 

More from NOKHAIZHAMMAD2021BSM

Developing a Conceptual Framework for Research (1).pptx
Developing a Conceptual Framework for Research (1).pptxDeveloping a Conceptual Framework for Research (1).pptx
Developing a Conceptual Framework for Research (1).pptxNOKHAIZHAMMAD2021BSM
 
Ghjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggig
GhjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggigGhjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggig
GhjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggigNOKHAIZHAMMAD2021BSM
 
Patient Careghhgjhgwugwghjsghjsgjsghusvhgshg
Patient CareghhgjhgwugwghjsghjsgjsghusvhgshgPatient Careghhgjhgwugwghjsghjsgjsghusvhgshg
Patient CareghhgjhgwugwghjsghjsgjsghusvhgshgNOKHAIZHAMMAD2021BSM
 
PN Lesson 12 Communicating with Patients.pptx
PN Lesson 12 Communicating with Patients.pptxPN Lesson 12 Communicating with Patients.pptx
PN Lesson 12 Communicating with Patients.pptxNOKHAIZHAMMAD2021BSM
 
bloodcompositionanditsfunctionson17-170209014518.pdf
bloodcompositionanditsfunctionson17-170209014518.pdfbloodcompositionanditsfunctionson17-170209014518.pdf
bloodcompositionanditsfunctionson17-170209014518.pdfNOKHAIZHAMMAD2021BSM
 
basicmeasurementsinepidemiology-201020073202.pdf
basicmeasurementsinepidemiology-201020073202.pdfbasicmeasurementsinepidemiology-201020073202.pdf
basicmeasurementsinepidemiology-201020073202.pdfNOKHAIZHAMMAD2021BSM
 
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdf
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdfSUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdf
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdfNOKHAIZHAMMAD2021BSM
 
Method of histological study L3.pptx
Method of histological study L3.pptxMethod of histological study L3.pptx
Method of histological study L3.pptxNOKHAIZHAMMAD2021BSM
 
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdf
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdfbloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdf
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdfNOKHAIZHAMMAD2021BSM
 
edemabyahammednaseem-210628024050.pdf
edemabyahammednaseem-210628024050.pdfedemabyahammednaseem-210628024050.pdf
edemabyahammednaseem-210628024050.pdfNOKHAIZHAMMAD2021BSM
 

More from NOKHAIZHAMMAD2021BSM (20)

Developing a Conceptual Framework for Research (1).pptx
Developing a Conceptual Framework for Research (1).pptxDeveloping a Conceptual Framework for Research (1).pptx
Developing a Conceptual Framework for Research (1).pptx
 
Ghjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggig
GhjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggigGhjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggig
Ghjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggig
 
Patient Careghhgjhgwugwghjsghjsgjsghusvhgshg
Patient CareghhgjhgwugwghjsghjsgjsghusvhgshgPatient Careghhgjhgwugwghjsghjsgjsghusvhgshg
Patient Careghhgjhgwugwghjsghjsgjsghusvhgshg
 
PN Lesson 12 Communicating with Patients.pptx
PN Lesson 12 Communicating with Patients.pptxPN Lesson 12 Communicating with Patients.pptx
PN Lesson 12 Communicating with Patients.pptx
 
pptx (19).pptx
pptx (19).pptxpptx (19).pptx
pptx (19).pptx
 
pptx (19).pptx
pptx (19).pptxpptx (19).pptx
pptx (19).pptx
 
Hematopiosis.pptx
Hematopiosis.pptxHematopiosis.pptx
Hematopiosis.pptx
 
bloodcompositionanditsfunctionson17-170209014518.pdf
bloodcompositionanditsfunctionson17-170209014518.pdfbloodcompositionanditsfunctionson17-170209014518.pdf
bloodcompositionanditsfunctionson17-170209014518.pdf
 
pptx.pptx
pptx.pptxpptx.pptx
pptx.pptx
 
chap004.ppt
chap004.pptchap004.ppt
chap004.ppt
 
basicmeasurementsinepidemiology-201020073202.pdf
basicmeasurementsinepidemiology-201020073202.pdfbasicmeasurementsinepidemiology-201020073202.pdf
basicmeasurementsinepidemiology-201020073202.pdf
 
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdf
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdfSUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdf
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdf
 
Method of histological study L3.pptx
Method of histological study L3.pptxMethod of histological study L3.pptx
Method of histological study L3.pptx
 
LEC 2 HISTO CELL MEMBRANE.pptx
LEC 2 HISTO CELL MEMBRANE.pptxLEC 2 HISTO CELL MEMBRANE.pptx
LEC 2 HISTO CELL MEMBRANE.pptx
 
Death due to natural diseases.pdf
Death due to natural diseases.pdfDeath due to natural diseases.pdf
Death due to natural diseases.pdf
 
hdnnonmlt-151222085444.pptx
hdnnonmlt-151222085444.pptxhdnnonmlt-151222085444.pptx
hdnnonmlt-151222085444.pptx
 
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdf
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdfbloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdf
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdf
 
bloodclotting-200418092606.pptx
bloodclotting-200418092606.pptxbloodclotting-200418092606.pptx
bloodclotting-200418092606.pptx
 
Autopsy1.pdf
Autopsy1.pdfAutopsy1.pdf
Autopsy1.pdf
 
edemabyahammednaseem-210628024050.pdf
edemabyahammednaseem-210628024050.pdfedemabyahammednaseem-210628024050.pdf
edemabyahammednaseem-210628024050.pdf
 

Recently uploaded

Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentInMediaRes1
 
AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.arsicmarija21
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxDr.Ibrahim Hassaan
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxEyham Joco
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaVirag Sontakke
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 

Recently uploaded (20)

Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media Component
 
AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptx
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptx
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of India
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 

Leukemia.pptx

  • 2. • Leukemia is a blood cancer caused by a rise in the number of white blood cells in your body. • Those white blood cells crowd out the red blood cells and platelets that your body needs to be healthy. The extra white blood cells don’t work right
  • 3. Leukemia Symptoms • Different types of leukemia can cause different problems. You might not notice any signs in the early stages of some forms. When you do have symptoms, they may include: • Weakness or fatigue • Bruising or bleeding easily • Fever or chills • Infections that are severe or keep coming back • Pain in your bones or joints • Headaches • Vomiting • Seizures • Weight loss • Night sweats • Shortness of breath • Swollen lymph nodes or organs like your spleen •
  • 4. • Blood has three types of cells: white blood cells that fight infection, red blood cells that carry oxygen, and platelets that help blood clot. • Every day, your bone marrow makes billions of new blood cells, and most of them are red cells. When you have leukemia, your body makes more white cells than it needs. • These leukemia cells can’t fight infection the way normal white blood cells do. And because there are so many of them, they start to affect the way your organs work. Over time, you may not have enough red blood cells to supply oxygen, enough platelets to clot your blood, or enough normal white blood cells to fight infection
  • 5. Leukemia Classification • Leukemia is grouped by how fast it develops and gets worse, and by which type of blood cell is involved. • The first group, how fast it develops, is divided into acute and chronic leukemia. • Acute leukemia happens when most of the abnormal blood cells don’t mature and can’t carry out normal functions. It can get bad very fast. • Chronic leukemia happens when there are some immature cells, but others are normal and can work the way they should. It gets bad more slowly than acute forms do. •
  • 6. • The second group, what type of cell is involved, is divided into lymphocytic and myelogenous leukemia. • Lymphocytic (or lymphoblastic) leukemia involves bone marrow cells that become lymphocytes, a kind of white blood cell. • Myelogenous (or myeloid) leukemia involves the marrow cells that create red blood cells, platelets, and other kinds of white blood cells
  • 7. Types of Leukemia • The four main types of leukemia are: • Acute lymphocytic leukemia (ALL). This is the most common form of childhood leukemia. It can spread to your lymph nodes and central nervous system. • Acute myelogenous leukemia (AML). This is the second most common form of childhood leukemia and one of the most common forms for adults. • Chronic lymphocytic leukemia (CLL). This is the other most common form of adult leukemia. Some kinds of CLL will be stable for years and won’t need treatment. But with others, your body isn’t able to create normal blood cells, and you’ll need treatment. • Chronic myelogenous leukemia (CML). With this form, you might not have noticeable symptoms. You might not be diagnosed with it until you have a routine blood test. People 65 and older have a higher risk of this type.
  • 8. How leukemia forms • In general, leukemia is thought to occur when some blood cells acquire changes (mutations) in their genetic material or DNA. A cell's DNA contains the instructions that tell a cell what to do. Normally, the DNA tells the cell to grow at a set rate and to die at a set time. In leukemia, the mutations tell the blood cells to continue growing and dividing. • When this happens, blood cell production becomes out of control. Over time, these abnormal cells can crowd out healthy blood cells in the bone marrow, leading to fewer healthy white blood cells, red blood cells and platelets, causing the signs and symptoms of leukemia.
  • 9. Risk factors • Previous cancer treatment. People who've had certain types of chemotherapy and radiation therapy for other cancers have an increased risk of developing certain types of leukemia. • Genetic disorders. Genetic abnormalities seem to play a role in the development of leukemia. Certain genetic disorders, such as Down syndrome, are associated with an increased risk of leukemia. • Exposure to certain chemicals. Exposure to certain chemicals, such as benzene — which is found in gasoline and is used by the chemical industry — is linked to an increased risk of some kinds of leukemia. • Smoking. Smoking cigarettes increases the risk of acute myelogenous leukemia. • Family history of leukemia. If members of your family have been diagnosed with leukemia, your risk of the disease may be increased.
  • 10. Cont……. • With regard to the specific genetic and environmental factors that are thought to be linked to leukemia, and what causes bone marrow cells to mutate, researchers are evaluating certain combinations of: • A genetic predisposition • Down syndrome • Human T-lymphotropic virus (HTLV) • Human immunodeficiency virus (HIV) • Exposure to petrochemicals, such as benzene • Extensive exposure to artificial ionizing radiation • Alkylating chemotherapy agents administered to treat other types of cancer • Tobacco use • Use of certain hair dyes
  • 11. Can Leukemia be cured? • While there is no cure for leukemia at this point in time, and the cancer can still recur, patients can reach a state of remission (in which there are no longer any signs or symptoms of cancer). These days, there are a range of advanced treatment options available for leukemia patients to achieve remission without recurrence, including: • Chemotherapy • Radiation therapy • Bone marrow transplants • Monoclonal antibody therapy • Immunotherapy • Clinical trials
  • 12. Treatments • Induction chemotherapy to bring about bone marrow remission. For adults, standard induction plans include prednisone, vincristine, and an anthracycline drug; other drug plans may include L-asparaginase or cyclophosphamide. For children with low-risk ALL, standard therapy usually consists of three drugs (prednisone, L-asparaginase, and vincristine) for the first month of treatment. • Consolidation therapy or intensification therapy to eliminate any remaining leukemia cells. There are many different approaches to consolidation, but it is typically a high-dose, multi-drug treatment that is undertaken for a few months. People with low- to average-risk ALL receive therapy with antimetabolite drugs such as methotrexate and 6-mercaptopurine (6-MP). People who are high-risk receive higher drug doses of these drugs, plus additional drugs. • CNS prophylaxis (preventive therapy) to stop cancer from spreading to the brain and nervous system in high-risk people. Standard prophylaxis may include radiation of the head and/or drugs delivered directly into the spine. • Maintenance treatments with chemotherapeutic drugs to prevent disease recurrence once remission has been achieved. Maintenance therapy usually involves lower drug doses and may continue for up to three years. • Alternatively, allogeneic bone marrow transplantation may be appropriate for high-risk or relapsed people.